Department of Gastroenterology, Odense University Hospital, Odense C, Denmark.
Department of Clinical Research, University of Southern Denmark, Odense C, Denmark.
Scand J Gastroenterol. 2022 Dec;57(12):1423-1429. doi: 10.1080/00365521.2022.2098050. Epub 2022 Jul 19.
Rebleeding is a frequent complication of peptic ulcer bleeding (PUB). The associated prognosis remains rather unclear because previous studies generally also included non-ulcer lesions.
We aimed to identify predictors for rebleeding; clarify the prognostic consequence of rebleeding; and develop a score for predicting rebleeding.
Nationwide cohort study of consecutive patients presenting to hospital with PUB in Denmark from 2006-2014. Logistic regression analyses were used to identify predictors for rebleeding, evaluate the association between rebleeding and 30-day mortality, and develop a score to predict rebleeding. Patients with persistent bleeding were excluded.
Among 19,258 patients (mean age 74 years, mean ASA-score 2.4), 10.8% rebled, and 10.2% died. Strongest predictors for rebleeding were endoscopic high-risk stigmata of bleeding (Odds Ratio (OR): 2.12 [95% Confidence Interval (CI): 1.91-2.36]), bleeding from duodenal ulcers (OR: 1.87 [95% CI: 1.69-2.08]), and presentation with hemodynamic instability (OR: 1.55 [95% CI: 1.38-1.73]). Among patients with all three factors (7.9% of total), 24% rebled, 50% with rebleeding failed endoscopic therapy, and 23% died. Rebleeding was associated with increased mortality (OR: 2.04 [95% CI: 1.78-2.32]). We were unable to develop an accurate score to predict rebleeding.
Rebleeding occurs in ∼10% of patients with PUB and is overall associated with a two-fold increase in 30-day mortality. Patients with hemodynamic instability, duodenal ulcers, and high-risk endoscopic stigmata are at highest risk of rebleeding. When rebleeding occurs in such patients, consultation with surgery and/or interventional radiology should be obtained prior to repeat endoscopy.
消化性溃疡出血(PUB)后再出血是一种常见的并发症。由于先前的研究通常也包括非溃疡性病变,因此其相关预后仍然相当不清楚。
我们旨在确定再出血的预测因素;阐明再出血的预后后果;并开发一种预测再出血的评分。
这是一项在丹麦进行的、针对 2006 年至 2014 年期间因 PUB 住院的连续患者的全国性队列研究。使用逻辑回归分析来确定再出血的预测因素,评估再出血与 30 天死亡率之间的关系,并开发一种预测再出血的评分。排除持续出血的患者。
在 19258 例患者中(平均年龄 74 岁,平均 ASA 评分为 2.4),10.8%的患者再出血,10.2%的患者死亡。再出血的最强预测因素是内镜下出血高危征象(比值比(OR):2.12 [95%置信区间(CI):1.91-2.36])、十二指肠溃疡出血(OR:1.87 [95% CI:1.69-2.08])和出现血流动力学不稳定(OR:1.55 [95% CI:1.38-1.73])。在具有这三个因素的患者中(占总数的 7.9%),24%的患者再出血,50%的再出血患者内镜治疗失败,23%的患者死亡。再出血与死亡率增加相关(OR:2.04 [95% CI:1.78-2.32])。我们无法开发出一种准确预测再出血的评分。
PUB 患者中约有 10%发生再出血,总体上与 30 天死亡率增加两倍相关。血流动力学不稳定、十二指肠溃疡和内镜高危征象的患者再出血风险最高。当此类患者发生再出血时,在重复进行内镜检查之前,应咨询外科医生和/或介入放射科医生。